Malcolm Campbell Award

The Award is given in alternate years to recognise work published in the preceding two years by individuals or groups which is of biological and/or medicinal chemistry interest, including discovery and/or process development, agrochemical and aromachemical research.  

In 2007 the award was made to a team from Organon, Newhouse including Johnny Bennett, Ton Bom, Alan Muir, Ronnie Palin, David Rees, Ming Zhang for the discovery of Sugammadex

Sugammadex is the 1st selective relaxant binding agent (SRBA). Sugammadex is specifically designed to quickly and safely reverse the effects of muscle relaxants used after general anaesthesia and is currently in late Phase III Clinical Trials.